Literature DB >> 9649575

Anti-idiotypic antibodies prevent the serologic detection of antiribosomal P autoantibodies in healthy adults.

Z J Pan1, C J Anderson, H A Stafford.   

Abstract

A subset of SLE patients has serologically detectable autoantibodies to the ribosomal P proteins (anti-P). We reported the discovery of covert anti-P antibodies and their masking IgG-inhibitory antibodies in the sera of healthy adults. The aim of this study was to determine if these IgG-inhibitory antibodies are anti-idiotypic antibodies (anti-Ids). IgG and IgG-depleted fractions of plasma from two healthy adults were assayed for inhibition of anti-P F(ab')2 binding to the ribosomal P proteins in immunoblot. Anti-P antibody activity was completely inhibited by plasma IgG, whereas there was no inhibition by IgG-depleted plasma. IgG-inhibitory antibodies recognized a cross-reactive epitope among anti-P from different SLE patients. Plasma IgG from one healthy adult was depleted of pepsin agglutinators and generic anti-F(ab')2 antibodies by adsorption with an affinity column prepared with normal IgG F(ab')2. Unretained IgG bound exclusively to anti-P F(ab')2 in ELISA. Using four affinity columns, we isolated IgG anti-Ids to anti-P antibodies from four healthy adults. These purified anti-Ids bound to anti-P F(ab')2 from a healthy adult and SLE patients. They did not bind to F(ab')2 fragments prepared from normal IgG or anti-dsDNA. Ribosomal antigens blocked this anti-Id-Id interaction. Purified anti-Ids inhibited the binding of anti-P F(ab')2 from patients to ribosomal P proteins. SLE patients without overt anti-P antibodies also possessed IgG anti-Ids to anti-P antibodies. We conclude that IgG-inhibitory antibodies are anti-Ids to anti-P antibodies, and are directed to public idiotopes on anti-P antibodies. These anti-Ids may be part of an Id network that regulates anti-P antibody expression, and perhaps pathogenicity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9649575      PMCID: PMC509083          DOI: 10.1172/JCI1969

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  35 in total

1.  Separation of univalent fragments from the bivalent rabbit antibody molecule by reduction of disulfide bonds.

Authors:  A NISONOFF; F C WISSLER; L N LIPMAN; D L WOERNLEY
Journal:  Arch Biochem Biophys       Date:  1960-08       Impact factor: 4.013

Review 2.  Idiotypic--anti-idiotypic interactions in man.

Authors:  R S Geha
Journal:  Am J Dis Child       Date:  1985-04

3.  Naturally occurring antibodies against nine common antigens in human sera. I. Detection, isolation and characterization.

Authors:  B Guilbert; G Dighiero; S Avrameas
Journal:  J Immunol       Date:  1982-06       Impact factor: 5.422

Review 4.  Genetics, expression, and function of idiotypes.

Authors:  K Rajewsky; T Takemori
Journal:  Annu Rev Immunol       Date:  1983       Impact factor: 28.527

5.  Towards a network theory of the immune system.

Authors:  N K Jerne
Journal:  Ann Immunol (Paris)       Date:  1974-01

6.  Human polyclonal and monoclonal IgG and IgM complement 3 nephritic factors: evidence for idiotypic commonality.

Authors:  G C Tsokos; A E Stitzel; A D Patel; M Hiramatsu; J E Balow; R E Spitzer
Journal:  Clin Immunol Immunopathol       Date:  1989-10

7.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

8.  Naturally occurring human antibodies to the F(ab')2 portion of IgG.

Authors:  H Nasu; D S Chia; D W Knutson; E V Barnett
Journal:  Clin Exp Immunol       Date:  1980-11       Impact factor: 4.330

9.  Expression of anti-idiotypic clones against auto-anti-DNA antibodies in normal individuals.

Authors:  M Zouali; A Eyquem
Journal:  Cell Immunol       Date:  1983-02-15       Impact factor: 4.868

10.  Studies of anti-F(ab')2 antibodies and possible immunologic control mechanisms in systemic lupus erythematosus.

Authors:  F Silvestris; A D Bankhurst; R P Searles; R C Williams
Journal:  Arthritis Rheum       Date:  1984-12
View more
  14 in total

1.  The Leishmania infantum acidic ribosomal protein LiP2a induces a prominent humoral response in vivo and stimulates cell proliferation in vitro and interferon-gamma (IFN-gamma) production by murine splenocytes.

Authors:  M Soto; C Alonso; J M Requena
Journal:  Clin Exp Immunol       Date:  2000-11       Impact factor: 4.330

Review 2.  Protective role of anti-idiotypic antibodies in autoimmunity--lessons for type 1 diabetes.

Authors:  Christiane S Hampe
Journal:  Autoimmunity       Date:  2012-02-23       Impact factor: 2.815

Review 3.  Anti-ribosomal-P antibodies in lupus nephritis, neuropsychiatric lupus, lupus hepatitis, and Chagas' disease: promising yet limited in clinical utility.

Authors:  Mary Abraham; Chris T Derk
Journal:  Rheumatol Int       Date:  2014-06-07       Impact factor: 2.631

4.  The immunogenicity of humanized and fully human antibodies: residual immunogenicity resides in the CDR regions.

Authors:  Fiona A Harding; Marcia M Stickler; Jennifer Razo; Robert B DuBridge
Journal:  MAbs       Date:  2010-05-01       Impact factor: 5.857

5.  Autoimmunity: increasing suspects in the CD4+ T cell lineup.

Authors:  Matthew T Palmer; Casey T Weaver
Journal:  Nat Immunol       Date:  2009-12-17       Impact factor: 25.606

6.  Lupus-specific kidney deposits of HSP90 are associated with altered IgG idiotypic interactions of anti-HSP90 autoantibodies.

Authors:  A Kenderov; V Minkova; D Mihailova; N Giltiay; S Kyurkchiev; I Kehayov; M Kazatchkine; S Kaveri; A Pashov
Journal:  Clin Exp Immunol       Date:  2002-07       Impact factor: 4.330

7.  Comparison of three assays for the detection of GAD65Ab-specific anti-idiotypic antibodies.

Authors:  Shilpa Oak; Jared Radtke; Mona Landin-Olsson; Carina Törn; Ake Lernmark; Christiane S Hampe
Journal:  J Immunol Methods       Date:  2009-09-23       Impact factor: 2.303

8.  The lack of anti-idiotypic antibodies, not the presence of the corresponding autoantibodies to glutamate decarboxylase, defines type 1 diabetes.

Authors:  Shilpa Oak; Lisa K Gilliam; Mona Landin-Olsson; Carina Törn; Ingrid Kockum; Christina R Pennington; Merrill J Rowley; Michael R Christie; J Paul Banga; Christiane S Hampe
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-26       Impact factor: 11.205

9.  Reactivity against complementary proteinase-3 is not increased in patients with PR3-ANCA-associated vasculitis.

Authors:  Henko Tadema; Cees G M Kallenberg; Coen A Stegeman; Peter Heeringa
Journal:  PLoS One       Date:  2011-03-17       Impact factor: 3.240

10.  Anti-idiotypic antibody specific to GAD65 autoantibody prevents type 1 diabetes in the NOD mouse.

Authors:  Xin Wang; Aixia Zhang; Yu Liu; Shi Chen; Zhenqing Feng; Wenbin Shang; Marlena Maziarz; Jared Radtke; Christiane S Hampe
Journal:  PLoS One       Date:  2012-02-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.